Papers

• Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs.
  Gowen BB, Fairman J, Dow S, Troyer R, Wong MH, Jung KH, Melby PC, Morrey JD.
  Antiviral Res. 2009 Jan;81(1):37-46. Epub 2008 Oct 7.

  PMID: 18840471 [PubMed - in process]

• Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study.
  Fairman J, Moore J, Lemieux M, Van Rompay K, Geng Y, Warner J, Abel K.
  Hum Vaccin. 2008 Jul 14;5(2). [Epub ahead of print]

  PMID: 18690014 [PubMed - as supplied by publisher]

• Efficacy of cationic lipid-DNA complexes (CLDC) on hepatitis B virus in transgenic mice.
  Morrey JD, Motter NE, Taro B, Lay M, Fairman J.
  Antiviral Res. 2008 Jul;79(1):71-9. Epub 2008 Feb 25.

  PMID: 18358544 [PubMed - indexed for MEDLINE]

• Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes.
  Gowen BB, Fairman J, Smee DF, Wong MH, Jung KH, Pace AM, Heiner ML, Bailey KW, Dow SW, Sidwell RW.
  Antiviral Res. 2006 Mar;69(3):165-72. Epub 2006 Jan 6.

  PMID: 16430975 [PubMed - indexed for MEDLINE]

• Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes.
  Higgins RJ, McKisic M, Dickinson PJ, Jimenez DF, Dow SW, Tripp LD, LeCouteur RA.
  Cancer Immunol Immunother. 2004 Apr;53(4):338-44. Epub 2003 Nov 13.

  PMID: 14618278 [PubMed - indexed for MEDLINE]

• Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously.
  Dow SW, Fradkin LG, Liggitt DH, Willson AP, Heath TD, Potter TA.
  J Immunol. 1999 Aug 1;163(3):1552-61.

  PMID: 10415059 [PubMed - indexed for MEDLINE]

^ back to top